Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Richard Law is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/03/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $8.31 | 80.4% | Richard Law46% | $29 → $15 | Maintains | Neutral | Get Alert |
| 03/03/2025 | CLDX | Buy Now | Celldex Therapeutics | $20.23 | 77.95% | Richard Law46% | $42 → $36 | Maintains | Neutral | Get Alert |
| 02/27/2025 | MLTX | Buy Now | MoonLake | $39.41 | 85.23% | Richard Law46% | $82 → $73 | Maintains | Buy | Get Alert |
| 02/13/2025 | MLYS | Buy Now | Mineralys Therapeutics | $16.52 | 45.23% | Richard Law46% | $28 → $24 | Maintains | Buy | Get Alert |
| 01/17/2025 | MLTX | Buy Now | MoonLake | $39.41 | 108.07% | Richard Law46% | $62 → $82 | Upgrade | Neutral → Buy | Get Alert |
| 09/30/2024 | CLDX | Buy Now | Celldex Therapeutics | $20.23 | 122.44% | Richard Law46% | → $45 | Initiates | → Neutral | Get Alert |
| 09/12/2024 | VRDN | Buy Now | Viridian Therapeutics | $14.85 | 108.75% | Richard Law46% | $25 → $31 | Maintains | Buy | Get Alert |
| 06/06/2024 | VRDN | Buy Now | Viridian Therapeutics | $14.85 | 54.88% | Richard Law46% | → $23 | Initiates | → Buy | Get Alert |
| 04/02/2024 | MLYS | Buy Now | Mineralys Therapeutics | $16.52 | 81.54% | Richard Law46% | → $30 | Initiates | → Buy | Get Alert |
| 04/02/2024 | OLMA | Buy Now | Olema Pharmaceuticals | $4.39 | 446.08% | Richard Law46% | → $24 | Initiates | → Buy | Get Alert |
| 04/02/2024 | RCKT | Buy Now | Rocket Pharmaceuticals | $8.31 | 369.03% | Richard Law46% | → $39 | Initiates | → Neutral | Get Alert |
| 04/02/2024 | MLTX | Buy Now | MoonLake | $39.41 | 57.32% | Richard Law46% | → $62 | Initiates | → Neutral | Get Alert |
| 08/11/2023 | GLUE | Buy Now | Monte Rosa Therapeutics | $5.67 | 93.83% | Richard Law46% | → $11 | Reiterates | Neutral → Neutral | Get Alert |
| 08/11/2023 | VERV | Buy Now | Verve Therapeutics | $5.76 | 437.73% | Richard Law46% | → $31 | Reiterates | Neutral → Neutral | Get Alert |
| 08/09/2023 | OLMA | Buy Now | Olema Pharmaceuticals | $4.39 | 309.56% | Richard Law46% | $16 → $18 | Maintains | Outperform | Get Alert |
| 08/09/2023 | BEAM | Buy Now | Beam Therapeutics | $22.81 | 106.05% | Richard Law46% | $46 → $47 | Maintains | Neutral | Get Alert |
| 08/08/2023 | MLYS | Buy Now | Mineralys Therapeutics | $16.52 | 123.9% | Richard Law46% | $38 → $37 | Maintains | Outperform | Get Alert |
| 08/08/2023 | CRSP | Buy Now | CRISPR Therapeutics | $42.49 | 48.27% | Richard Law46% | $62 → $63 | Maintains | Neutral | Get Alert |
| 08/04/2023 | KYMR | Buy Now | Kymera Therapeutics | $31.74 | 16.57% | Richard Law46% | $36 → $37 | Maintains | Neutral | Get Alert |
| 06/13/2023 | NTLA | Buy Now | Intellia Therapeutics | $8.69 | 775.07% | Richard Law46% | → $76 | Reiterates | Outperform → Outperform | Get Alert |
| 06/05/2023 | KYMR | Buy Now | Kymera Therapeutics | $31.74 | 13.42% | Richard Law46% | → $36 | Reiterates | Neutral → Neutral | Get Alert |
| 05/16/2023 | MLYS | Buy Now | Mineralys Therapeutics | $16.52 | 129.95% | Richard Law46% | → $38 | Reiterates | Outperform → Outperform | Get Alert |
| 05/12/2023 | FIXX | Buy Now | Homology Medicines | — | — | Richard Law46% | → $36 | Reiterates | Neutral → Neutral | Get Alert |
| 05/12/2023 | GLUE | Buy Now | Monte Rosa Therapeutics | $5.67 | 93.83% | Richard Law46% | → $11 | Reiterates | Neutral → Neutral | Get Alert |
| 05/09/2023 | CRSP | Buy Now | CRISPR Therapeutics | $42.49 | 45.92% | Richard Law46% | $65 → $62 | Maintains | Neutral | Get Alert |
| 05/08/2023 | EDIT | Buy Now | Editas Medicine | $1.38 | 914.49% | Richard Law46% | $15 → $14 | Maintains | Neutral | Get Alert |
| 05/08/2023 | ARVN | Buy Now | Arvinas | $8.59 | 610.13% | Richard Law46% | → $61 | Reiterates | → Outperform | Get Alert |
| 05/05/2023 | KYMR | Buy Now | Kymera Therapeutics | $31.74 | 13.42% | Richard Law46% | $39 → $36 | Maintains | Neutral | Get Alert |
| 03/17/2023 | GLUE | Buy Now | Monte Rosa Therapeutics | $5.67 | 93.83% | Richard Law46% | $12 → $11 | Maintains | Neutral | Get Alert |
| 03/16/2023 | MLYS | Buy Now | Mineralys Therapeutics | $16.52 | 129.95% | Richard Law46% | $40 → $38 | Maintains | Outperform | Get Alert |
| 03/10/2023 | OLMA | Buy Now | Olema Pharmaceuticals | $4.39 | 150.28% | Richard Law46% | $12 → $11 | Maintains | Outperform | Get Alert |
| 03/07/2023 | MLYS | Buy Now | Mineralys Therapeutics | $16.52 | 142.06% | Richard Law46% | → $40 | Initiates | → Outperform | Get Alert |
| 02/24/2023 | NTLA | Buy Now | Intellia Therapeutics | $8.69 | 775.07% | Richard Law46% | $88 → $76 | Maintains | Outperform | Get Alert |
| 02/24/2023 | ARVN | Buy Now | Arvinas | $8.59 | 610.13% | Richard Law46% | $81 → $61 | Maintains | Outperform | Get Alert |
| 02/24/2023 | KYMR | Buy Now | Kymera Therapeutics | $31.74 | 22.87% | Richard Law46% | $32 → $39 | Maintains | Neutral | Get Alert |
| 02/23/2023 | EDIT | Buy Now | Editas Medicine | $1.38 | 986.96% | Richard Law46% | $13 → $15 | Maintains | Neutral | Get Alert |
| 02/22/2023 | CRSP | Buy Now | CRISPR Therapeutics | $42.49 | 52.98% | Richard Law46% | $78 → $65 | Maintains | Neutral | Get Alert |
| 02/22/2023 | OLMA | Buy Now | Olema Pharmaceuticals | $4.39 | 173.04% | Richard Law46% | → $12 | Initiates | → Outperform | Get Alert |
| 12/06/2022 | NTLA | Buy Now | Intellia Therapeutics | $8.69 | 913.24% | Richard Law46% | $109 → $88 | Maintains | Outperform | Get Alert |
| 12/06/2022 | EDIT | Buy Now | Editas Medicine | $1.38 | 842.03% | Richard Law46% | → $13 | Assumes | → Neutral | Get Alert |
| 12/06/2022 | KYMR | Buy Now | Kymera Therapeutics | $31.74 | 0.82% | Richard Law46% | $47 → $32 | Downgrade | Outperform → Neutral | Get Alert |
| 11/08/2022 | BEAM | Buy Now | Beam Therapeutics | $22.81 | 132.35% | Richard Law46% | $65 → $53 | Maintains | Neutral | Get Alert |
| 11/04/2022 | KYMR | Buy Now | Kymera Therapeutics | $31.74 | 48.08% | Richard Law46% | $61 → $47 | Maintains | Outperform | Get Alert |
| 11/04/2022 | NTLA | Buy Now | Intellia Therapeutics | $8.69 | 1155.04% | Richard Law46% | $101 → $109 | Maintains | Outperform | Get Alert |
| 11/02/2022 | CRSP | Buy Now | CRISPR Therapeutics | $42.49 | 83.57% | Richard Law46% | $90 → $78 | Maintains | Neutral | Get Alert |
| 10/06/2022 | VERV | Buy Now | Verve Therapeutics | $5.76 | 732.61% | Richard Law46% | → $48 | Initiates | → Neutral | Get Alert |
| 08/16/2022 | FIXX | Buy Now | Homology Medicines | — | — | Richard Law46% | $55.8 → $57.78 | Maintains | Neutral | Get Alert |
| 08/10/2022 | KYMR | Buy Now | Kymera Therapeutics | $31.74 | 92.19% | Richard Law46% | $60 → $61 | Maintains | Outperform | Get Alert |
| 08/09/2022 | CRSP | Buy Now | CRISPR Therapeutics | $42.49 | 111.81% | Richard Law46% | $74 → $90 | Maintains | Neutral | Get Alert |
| 08/05/2022 | ARVN | Buy Now | Arvinas | $8.59 | 808.03% | Richard Law46% | $98 → $78 | Maintains | Outperform | Get Alert |
| 05/17/2022 | FIXX | Buy Now | Homology Medicines | — | — | Richard Law46% | $48.6 → $37.8 | Maintains | Neutral | Get Alert |
| 05/06/2022 | NTLA | Buy Now | Intellia Therapeutics | $8.69 | 1028.38% | Richard Law46% | $100 → $98 | Maintains | Outperform | Get Alert |
| 04/28/2022 | CRSP | Buy Now | CRISPR Therapeutics | $42.49 | 83.57% | Richard Law46% | → $78 | Initiates | → Neutral | Get Alert |
| 04/28/2022 | ARVN | Buy Now | Arvinas | $8.59 | 1110.71% | Richard Law46% | → $104 | Initiates | → Outperform | Get Alert |
| 04/28/2022 | BEAM | Buy Now | Beam Therapeutics | $22.81 | 171.81% | Richard Law46% | → $62 | Initiates | → Neutral | Get Alert |
| 04/28/2022 | GLUE | Buy Now | Monte Rosa Therapeutics | $5.67 | 234.8% | Richard Law46% | → $19 | Initiates | → Neutral | Get Alert |
| 04/28/2022 | KYMR | Buy Now | Kymera Therapeutics | $31.74 | 98.49% | Richard Law46% | → $63 | Initiates | → Outperform | Get Alert |
| 04/28/2022 | FIXX | Buy Now | Homology Medicines | — | — | Richard Law46% | → $48.6 | Initiates | → Neutral | Get Alert |
| 04/28/2022 | NTLA | Buy Now | Intellia Therapeutics | $8.69 | 1051.41% | Richard Law46% | → $100 | Initiates | → Outperform | Get Alert |
